Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-10-31
pubmed:abstractText
Paeonol, a major phenolic component of Moutan Cortex, is known to have anti-inflammatory activity. However, the effect of Paeonol on colitis has not been evaluated and the molecular mechanism of its anti-inflammatory action remains unknown. The aim of this study was to determine if Paeonol enema attenuates trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice. We also investigated the effects of Paeonol in colon cancer-derived CW-2 cells and T cell leukemia-derived Jurkat cells treated with tumor necrosis factor alpha (TNFalpha) and/or interferon gamma (IFNgamma), which play critical roles in TNBS-induced colitis. Paeonol enema attenuated TNBS-induced colitis judging by body weigh reduction, colon length and histological score. Myeloperoxidase activity and inducible nitric oxide synthase (iNOS) production in the colon were also reduced with Paeonol enema. In CW-2 cells, Paeonol inhibited iNOS protein and mRNA expression induced by costimulation of TNFalpha and IFNgamma. Furthermore, Paeonol reduced TNFalpha-induced NF-kappaB transactivation and IFNgamma-induced STAT1 transactivation in CW-2 cells and also in Jurkat cells. These findings suggest that Paeonol enema may be useful for the treatment of colitis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0041-008X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
217
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35-42
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16928387-Acetophenones, pubmed-meshheading:16928387-Animals, pubmed-meshheading:16928387-Anti-Inflammatory Agents, pubmed-meshheading:16928387-Colitis, pubmed-meshheading:16928387-Colon, pubmed-meshheading:16928387-Dose-Response Relationship, Drug, pubmed-meshheading:16928387-Female, pubmed-meshheading:16928387-Gene Expression Regulation, Enzymologic, pubmed-meshheading:16928387-Humans, pubmed-meshheading:16928387-Interferon-gamma, pubmed-meshheading:16928387-Jurkat Cells, pubmed-meshheading:16928387-Mice, pubmed-meshheading:16928387-Mice, Inbred BALB C, pubmed-meshheading:16928387-NF-kappa B, pubmed-meshheading:16928387-Nitric Oxide Synthase Type II, pubmed-meshheading:16928387-Promoter Regions, Genetic, pubmed-meshheading:16928387-RNA, Messenger, pubmed-meshheading:16928387-STAT1 Transcription Factor, pubmed-meshheading:16928387-Transcriptional Activation, pubmed-meshheading:16928387-Trinitrobenzenesulfonic Acid, pubmed-meshheading:16928387-Tumor Necrosis Factor-alpha
pubmed:year
2006
pubmed:articleTitle
Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation.
pubmed:affiliation
Molecular Biology and Pathogenesis of Gastroenterology, School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan. kio@med.nagoya-u.ac.jp <kio@med.nagoya-u.ac.jp>
pubmed:publicationType
Journal Article